FDA Drug recall D-0635-2018
B-complex (B1-200mg, B2-4mg, B3-200mg,B5-4mg,B6-4mg) /mL, 5 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101,…
- FDA Drug
- Class II
- terminated
- Published 2018-04-25
On 2018-04-25 the FDA classified a Class II recall of B-complex (B1-200mg, B2-4mg, B3-200mg,B5-4mg,B6-4mg) /mL, 5 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101,… by Partell Specialty Pharmacy, citing lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0635-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-03-22 |
| Published | 2018-04-25 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Partell Specialty Pharmacy |
| Distribution | NV |
Product
B-complex (B1-200mg, B2-4mg, B3-200mg,B5-4mg,B6-4mg) /mL, 5 mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800
Reason
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Identifiers
| code_info | Lot#: 20180205@18, BUD 04/06/2018; 20180126@28, BUD 03/27/2018; 20180126@22, BUD 03/27/2018; 20180205@9, BUD 04/06/2018; 20180214@17, BUD 04/14/2018. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0635-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.